How should I treat a patient with hypocalcemia (serum calcium 6.6 mg/dL) and hypomagnesemia (serum magnesium 0.6 mg/dL)?

Immediate Management: Correct Magnesium FIRST, Then Calcium

You must correct the hypomagnesemia before attempting to treat the hypocalcemia—the low magnesium is causing PTH resistance and impaired PTH secretion, making calcium replacement ineffective until magnesium is repleted. 1

Critical First Steps

1. Assess Clinical Severity Immediately

• Check for life-threatening symptoms: seizures, laryngospasm, tetany, cardiac arrhythmias
• Obtain 12-lead EKG looking for prolonged QTc (>0.45s men, >0.47s women) 1
• Assess for neuromuscular irritability (Chvostek's, Trousseau's signs) 2

2. Magnesium Replacement Protocol (PRIORITY)

The hypocalcemia will NOT correct until magnesium is normalized because magnesium is a cofactor for adenylate cyclase and is required for PTH secretion and action 1, 3, 4.

For symptomatic patients or Mg <0.8 mg/dL:

• Give IV magnesium sulfate 1-2g over 15-30 minutes, followed by continuous infusion
• Monitor cardiac rhythm during administration 5

For asymptomatic patients:

• Oral magnesium replacement (magnesium oxide, citrate, or aspartate) 400-800mg elemental magnesium daily in divided doses 5

3. Concurrent Calcium Management

If severe symptoms present (seizures, tetany, laryngospasm) OR calcium <7.5 mg/dL:

• IV calcium gluconate bolus: 90-180mg elemental calcium (1-2 ampules of 10% calcium gluconate) over 10-20 minutes with cardiac monitoring 1

  • Critical warning: Rapid infusion can cause cardiac arrest—always use cardiac monitoring 1
  • Use large bore IV with secure access (calcium gluconate preferred over calcium chloride due to lower tissue necrosis risk if extravasation occurs) 1

• Followed by continuous infusion: Mix 10 ampules (900mg elemental calcium) in 1L D5W or normal saline, start at 100mL/hr 1

  • Do NOT add bicarbonate or phosphate to solution (forms insoluble calcium salts) 1
  • Monitor calcium every 6 hours initially, then daily until stable 1

Simultaneously start oral therapy:

• Calcitriol 0.25-0.5μg twice daily (short half-life 5-8 hours requires divided dosing) 1
• Oral calcium supplements 1-2g elemental calcium daily in divided doses with meals 1

Key Mechanistic Understanding

The magnesium deficiency creates a functional hypoparathyroid state through two mechanisms 3, 4, 6:

1. Impaired PTH secretion from parathyroid glands
2. End-organ resistance to PTH in bone and kidney

This explains why calcium replacement alone fails—you're treating the symptom (low calcium) without addressing the cause (magnesium-induced PTH dysfunction). Once magnesium is corrected, PTH levels normalize and calcium follows 4, 6.

Monitoring Protocol

Initial phase (unstable):

• Serum calcium, magnesium, phosphorus: every 6 hours until stable 1
• Check albumin to calculate corrected calcium 2, 1
• Continuous cardiac monitoring if symptomatic 1

After stabilization:

• Recheck electrolytes within 2-3 days after dose adjustments 1
• Once stable: calcium, magnesium, phosphorus, albumin every 3-12 months 1

Common Pitfalls to Avoid

1. Attempting to correct calcium without addressing magnesium first—this is the most critical error and will result in refractory hypocalcemia 3, 4, 7

2. Giving calcium too rapidly—can cause fatal cardiac arrhythmias; always use cardiac monitoring 1

3. Using calcium chloride instead of calcium gluconate—higher risk of tissue necrosis with extravasation 1

4. Forgetting to check PTH levels—will likely be inappropriately low or normal despite hypocalcemia, confirming functional hypoparathyroidism 4, 6

5. Not checking for underlying causes of hypomagnesemia: PPI use, diuretics, diarrhea, malabsorption, alcohol use 5, 7

Target Goals

• Serum calcium: Low-normal range (8.0-8.5 mg/dL) or slightly below to minimize hypercalciuria risk 1
• Serum magnesium: Normal range (1.7-2.2 mg/dL)
• Symptom resolution: No tetany, normal QTc interval, no paresthesias